Abstract:Brief Description of the Purpose of the StudyTo investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions.Methods49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis.Main ResultsBiopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis.Importance of the ConclusionsFor pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions. Brief Description of the Purpose of the StudyTo investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions. To investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions. Methods49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis. 49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis. Main ResultsBiopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis. Biopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis. Importance of the ConclusionsFor pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions. For pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions.

The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Clinical value of contrast-enhanced ultrasound versus conventional ultrasound in biopsy of focal liver lesions

The application of contrast enhanced ultrasound for core needle biopsy of subpleural pulmonary lesions: retrospective analysis in 92 patients

A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.

Guiding and controlling percutaneous pancreas biopsies with contrast-enhanced ultrasound: target lesions are not localized on B-mode ultrasound.

The Value of Contrast-Enhanced Ultrasound Guided Biopsy in Hepatic Space-Occupying Lesions

Clinical Value of Contrast-Enhanced Ultrasonography in the Characterization of Focal Liver Lesions: a Prospective Multicenter Trial.

The Role of Contrast-Enhanced Ultrasound in Selection Indication and Improveing Diagnosis for Transthoracic Biopsy in Peripheral Pulmonary and Mediastinal Lesions

The value of contrast-enhanced ultrasound in guiding biopsy of hepatic space-occupying lesions

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis

Guidance and Control of Percutaneous Biopsy in Pancreatic Lesions with Contrast Enhanced Ultrasound

The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.

Contrast-enhanced Sonography in Differential Diagnosis of Focal Hypoechoic Lesions in Fatty Liver

Comparison Of Contrast-Enhanced Ultrasound And Conventional Ultrasound For Guiding Peripheral Pulmonary Biopsies

Analysis of false negative in malignant liver tumor biopsies―importance of contrast-enhanced ultrasound

Application of contrast-enhanced ultrasonography in improving the success rate of percutaneous biopsy for peripheral pulmonary lesions

Contrast-enhanced ultrasound-guided biopsy improved diagnostic accuracy in patients with hepatitis: A prospective multicenter study of 2056 patients

Diagnostic Performance of Contrast-Enhanced Ultrasound for Complex Cystic Focal Liver Lesions: Blinded Reader Study

Contrast-Enhanced Ultrasound Guided Biopsy of Undetermined Abdominal Lesions: A Multidisciplinary Decision-Making Approach

A Prospective Multicenter Study on the Additive Value of Contrast-Enhanced Ultrasound for Biopsy Decision of Ultrasound BI-RADS 4 Breast Lesions